Pemetrexed Market: Industry Dynamics, Growth Drivers, Competitive Landscape, and Business Insights with Market Trends and Future Projections (2023-2031)
Global Pemetrexed Market Highlights: The global pemetrexed market size , valued at USD 2.27 billion in 2022 , is expected to grow steadily, reaching USD 2.61 billion by 2031 , at a CAGR of 1.6% during the forecast period (2023–2031). According to the latest report by Straits Research , this growth is driven by increasing incidences of cancer, advancements in chemotherapy treatments, and growing healthcare investments worldwide. Pemetrexed is an antifolate chemotherapy drug used primarily in the treatment of malignant pleural mesothelioma and non-squamous non-small cell lung cancer (NSCLC). Its effectiveness in targeting rapidly dividing cancer cells has made it a critical component in oncology treatments. Identify your true competitors in the marketplace with the Market Share Analysis, which provides insights into market positioning, percentage of market share, and segmented revenue of the Pemetrexed Market. Get a Full PDF Sample Copy of the Re...